Telmisartan and Insulin Resistance in HIV (TAILoR): protocol for a dose-ranging phase II randomised open-labelled trial of telmisartan as a strategy for the reduction of insulin resistance in HIV-positive individuals on combination antiretroviral therapySudeep Pushpakom, Munir Pirmohamed, Jiten Vora et al.|BMJ Open|2015Cited by 29
TAILoR (TelmisArtan and InsuLin Resistance in Human Immunodeficiency Virus [HIV]): An Adaptive-design, Dose-ranging Phase IIb Randomized Trial of Telmisartan for the Reduction of Insulin Resistance in HIV-positive Individuals on Combination Antiretroviral TherapySudeep Pushpakom, John Whitehead, Ruwanthi Kolamunnage‐Dona et al.|Clinical Infectious Diseases|2019Cited by 27